نتایج جستجو برای: thyroid related immune orbitopathy

تعداد نتایج: 1476500  

Journal: :European thyroid journal 2012
C Daumerie A Boschi P Perros

The pathogenesis of Graves' orbitopathy (GO) remains unknown. The hypothesis of a causal relationship between autoimmunity against the TSH receptor (TSHR) and GO is supported by clinical studies. Radioiodine treatment is associated with worsening or new onset of GO, possibly via antigen shedding or by inducing hypothyroidism. The coexistence of thyroid cancer with Graves' disease (GD) and GO is...

Journal: :Genetics and molecular research : GMR 2016
S L Hsu P Y Lee C H Chang C H Chen

Thyroid orbitopathy (TO) is an autoimmune disease that is complicated by ocular surface disorders, leading to discomfort. Dry eye is very prevalent in patients with TO. Recent studies on the pathogenesis of dry eye have focused on the inflammatory process, and some supporting evidence has been discovered. Because TO is a disorder of autoimmune origin, we assumed that the association between TO ...

Journal: :Ophthalmology 2006
Guy J Ben Simon Hasan M Syed Seongmu Lee Debbie Y Wang Robert M Schwarcz John D McCann Robert A Goldberg

PURPOSE To evaluate the effect of deep lateral wall orbital decompression with intraconal fat debulking on strabismus in thyroid-related orbitopathy (TRO) patients using automated Hess screen (AHS). DESIGN Prospective nonrandomized clinical study. PARTICIPANTS Eleven TRO patients (19 surgeries) operated on at the Jules Stein Eye Institute from January, 2004, through December, 2004. METHOD...

2017
Edyta Pawlak-Adamska Irena Frydecka Marek Bolanowski Anna Tomkiewicz Anna Jonkisz Lidia Karabon Anna Partyka Oskar Nowak Marek Szalinski Jacek Daroszewski

Graves' disease, an autoimmune disease with heterogeneous symptoms including Graves' orbitopathy, has a combined genetic/environmental background, where variations within CD28/CTLA-4/ICOS genes are considered as disease markers.Association of CD28c.17+3T>C(rs3116496), CTLA-4g.319C>T(rs5742909), CTLA-4c.49A>G(rs231775), CTLA-4g.*642AT(8_33), CT60(rs3087243), Jo31(rs11571302), ICOSc.1554+4GT(8_15...

Journal: :Ophthalmic plastic and reconstructive surgery 2007
Bobby S Korn Seong-Wook Seo Leah Levi David B Granet Don O Kikkawa

PURPOSE To report the development of optic neuropathy after botulinum A toxin injection for restrictive myopathy from thyroid-related orbitopathy (TRO). METHODS We retrospectively reviewed the records of three patients with TRO who underwent botulinum A toxin injection for restrictive myopathy and subsequently developed optic neuropathy. Development of optic neuropathy was measured by visual ...

2014
Jiun-Yo Lin Shwu-Jiuan Sheu

Background: Restrictive strabismus is a common feature of Thyroid-Related Ophthalmopathy (TRO) causing intractable diplopia. We reviewed the surgical outcome for TRO patients. Methods: We retrospectively reviewed patients of TRO who underwent strabismus surgery from January, 1998 to September, 2012. Preoperative characteristics were recorded such as age, sex, disease severity, presence of compr...

2013
Roman Junik

The authors of guidelines provide 100 recommendations describing many intensively discussed issues. Among them is hepatotoxicity of PTU and limitation of PTU treatment mainly to the first trimester of pregnancy. Methimazole becomes first line ATD for patients with new onset of Graves’ disease. Graves’ orbitopathy (GO) is classified according to its clinical activity and severity. Deterioration ...

2016
Camille Louvet Annamaria De Bellis Bruno Pereira Claire Bournaud Antony Kelly Salwan Maqdasy Beatrice Roche Francoise Desbiez Francoise Borson-Chazot Igor Tauveron Marie Batisse-Lignier

The risk of cancer is relatively higher in Graves' patients presenting simultaneously with thyroid nodules. Radioiodine (RAI) therapy recommended in high-risk differentiated thyroid carcinoma may be associated with worsening of a pre-existing Graves' orbitopathy (GO) or developing a new onset. The impact of RAI therapy in patients with differentiated thyroid cancer on the course of a pre-exisit...

Journal: :Nuclear medicine review. Central & Eastern Europe 2002
Petr Vlcek

In 1999 dr Petr Vlcek (Fig. 2) became the head of the Clinic and under his leadership the Clinic continues its diagnostic, therapeutic, scientific and pedagogic work. Since 2001 the Clinic has housed the Centre for thyroid oncology and endocrine orbitopathy of the 2nd Faculty of Medicine, Charles University, which covers the whole Czech Republic. All the equipment and procedures fulfill the con...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید